The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Screening for breast cancer with mammography
Abstract
BACKGROUND: A variety of estimates of the benefits and harms of mammographic screening for breast cancer have been published and national policies vary. OBJECTIVES: To assess the effect of screening for breast cancer with mammography on mortality and morbidity. SEARCH STRATEGY: We searched PubMed (June 2005). SELECTION CRITERIA: Randomised trials comparing mammographic screening with no mammographic screening. DATA COLLECTION AND ANALYSIS: Both authors independently extracted data. Study authors were contacted for additional information. MAIN RESULTS: Seven completed and eligible trials involving half a million women were identified. We excluded a biased trial from analysis. Two trials with adequate randomisation did not show a significant reduction in breast cancer mortality, relative risk (RR) 0.93 (95% confidence interval 0.80 to 1.09) at 13 years; four trials with suboptimal randomisation showed a significant reduction in breast cancer mortality, RR 0.75 (0.67 to 0.83) (P = 0.02 for difference between the two estimates). RR for all six trials combined was 0.80 (0.73 to 0.88). The two trials with adequate randomisation did not find an effect of screening on cancer mortality, including breast cancer, RR 1.02 (0.95 to 1.10) after 10 years, or on all-cause mortality, RR 1.00 (0.96 to 1.04) after 13 years. We found that breast cancer mortality was an unreliable outcome that was biased in favour of screening, mainly because of differential misclassification of cause of death. Numbers of lumpectomies and mastectomies were significantly larger in the screened groups, RR 1.31 (1.22 to 1.42) for the two adequately randomised trials; the use of radiotherapy was similarly increased. AUTHORS' CONCLUSIONS: Screening likely reduces breast cancer mortality. Based on all trials, the reduction is 20%, but as the effect is lower in the highest quality trials, a more reasonable estimate is a 15% relative risk reduction. Based on the risk level of women in these trials, the absolute risk reduction was 0.05%. Screening also leads to overdiagnosis and overtreatment, with an estimated 30% increase, or an absolute risk increase of 0.5%. This means that for every 2000 women invited for screening throughout 10 years, one will have her life prolonged. In addition, 10 healthy women, who would not have been diagnosed if there had not been screening, will be diagnosed as breast cancer patients and will be treated unnecessarily. It is thus not clear whether screening does more good than harm. Women invited to screening should be fully informed of both benefits and harms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Doll, R., & Peto, R. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1192 · Cited by 3,927
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY
Tabár, L., Gad, A., Holmberg, L. H., Ljungquist, U., Fagerberg, C. J. G., Baldetorp, L., Gröntoft, O., Lundström, B., Månson, J. C., Eklund, G., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92204-4 · Cited by 1,781
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force
Humphrey, L. L., Helfand, M., Chan, B. K. S., & Woolf, S. H. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00012 · Cited by 1,137
Efficacy of screening mammography. A meta-analysis
Kerlikowske, K. M. (1995) · JAMA · doi:10.1001/jama.273.2.149 · Cited by 1,131
Boyd, N. F., Byng, J. W., Jong, R. A., Fishell, E. K., Little, L. E., Miller, A. B., Lockwood, G. A., Tritchler, D. L., & Yaffe, M. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.670 · Cited by 1,105
Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations
Elmore, J. G., Barton, M. B., Moceri, V. M., Polk, S., Arena, P. J., & Fletcher, S. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381601 · Cited by 1,053
Darby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials
(1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332202 · Cited by 1,012
Breast cancer screening with mammography: overview of Swedish randomised trials
Nyström, L., Wall, S., Rutqvist, L. E., Lindgren, A., Lindqvist, M., Rydén, S., Andersson, J., Bjurstam, N., Fagerberg, G., Frisell, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91067-v · Cited by 968
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Andersson, I., Aspegren, K., Janzon, L., Landberg, T., Lindholm, K., Linell, F., Ljungberg, O., Ranstam, J., & Sigfússon, B. (1988) · BMJ · doi:10.1136/bmj.297.6654.943 · Cited by 916
Miller, A. B., Baines, C. J., To, T. M., & Wall, C. (1992) · Europe PMC (PubMed Central) · Cited by 864
Is screening for breast cancer with mammography justifiable?
Gøtzsche, P. C., & Olsen, O. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06065-1 · Cited by 853
Self-citationReport of the International Workshop on Screening for Breast Cancer
Fletcher, S. W., Black, W., Harris, R., Rimer, B. K., & Shapiro, S. (1993) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/85.20.1644 · Cited by 792
Tabar, L., Yen, M.-F., Vitak, B., Chen, H.-H. T., Smith, R. A., & Duffy, S. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13143-1 · Cited by 742
UPDATE OF THE SWEDISH TWO-COUNTY PROGRAM OF MAMMOGRAPHIC SCREENING FOR BREAST CANCER
Tabàr, L., Fagerberg, G., Duffy, S. W., Day, N. E., Gad, A., & Gröntoft, O. (1992) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)02494-0 · Cited by 731
Cochrane review on screening for breast cancer with mammography
Olsen, O., & Gøtzsche, P. C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06449-2 · Cited by 710
Self-citationEnthusiasm for Cancer Screening in the United States
Schwartz, L. M. (2004) · JAMA · doi:10.1001/jama.291.1.71 · Cited by 688
Incidence of and Treatment for Ductal Carcinoma In Situ of the Breast
Ernster, V. L. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530360023033 · Cited by 626
Tab�r, L., Vitak, B., Chen, H.-H. T., Yen, M.-F., Duffy, S. W., & Smith, R. A. (2001) · Cancer · doi:10.1002/1097-0142(20010501)91:9<1724::aid-cncr1190>3.0.co;2-v · Cited by 560
Efficacy of breast cancer screening by age. New results swedish two-county trial
Tabar, L., Fagerberg, G., Chen, H.-H., Duffy, S. W., Smart, C. R., Gad, A., & Smith, R. A. (1995) · Cancer · doi:10.1002/1097-0142(19950515)75:10<2507::aid-cncr2820751017>3.0.co;2-h · Cited by 557
Miller, A. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1490 · Cited by 512
Periodic Breast Cancer Screening in Reducing Mortality From Breast Cancer
Shapiro, S. (1971) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1971.03180240027005 · Cited by 499
Psychological and Behavioral Implications of Abnormal Mammograms
Lerman, C., Track, B., Rimer, B. K., Boyce, A., Jepson, C., & Engstrom, P. F. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-657 · Cited by 481
THE SWEDISH TWO-COUNTY TRIAL TWENTY YEARS LATER
Tabár, L., Vitak, B., Chen, H.-H., Duffy, S. W., Yen, M.-F., Chiang, C.-F., Krusemo, U. B., Tot, T., & Smith, R. A. (2000) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(05)70191-3 · Cited by 460
Screening for Breast Cancer: Recommendations and Rationale
U.S. Preventive Services Task Force* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00011 · Cited by 456
Edinburgh trial of screening for breast cancer: mortality at seven years
HUGGINS, A. (1990) · The Lancet · doi:10.1016/0140-6736(90)90066-e · Cited by 445
Periodic Screening for Breast Cancer: The Health Insurance Plan Project and Its Sequelae, 1963-1986
Miller, A. B., Shapiro, S., Venet, W., Strax, P., & Venet, L. (1989) · Journal of Public Health Policy · doi:10.2307/3342801 · Cited by 438
Hendrick, R. E., Smith, R. A., Rutledge, J. H., & Smart, C. R. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.87 · Cited by 419
Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies
Nielsen, M., Thomsen, J., Primdahl, S., Dyreborg, U., & Andersen, J. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.296 · Cited by 418
Self-citationMiller, A. B., To, T., Baines, C. J., & Wall, C. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00005 · Cited by 394
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening
Alexander, F., Anderson, T., Brown, H., Forrest, A., Hepburn, W., Kirkpatrick, A., Muir, B., Prescott, R., & Smith, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07413-3 · Cited by 388
Mammographic Screening for Breast Cancer
Fletcher, S. W., & Elmore, J. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp021804 · Cited by 378
Regular self-examination or clinical examination for early detection of breast cancer
Kösters, J. P., & Gøtzsche, P. C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003373 · Cited by 372
Self-citationTabar, L., Fagerberg, G., Duffy, S. W., & Day, N. E. (1989) · Journal of Epidemiology and Community Health · doi:10.1136/jech.43.2.107 · Cited by 355
Puffer, S., Torgerson, D., & Watson, J. (2003) · BMJ · doi:10.1136/bmj.327.7418.785 · Cited by 351
Tabár, L., Faberberg, G., Day, N., & Holmberg, L. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.112 · Cited by 318
Comparison of Screening Mammography in the United States and the United Kingdom
Smith-Bindman, R. (2003) · JAMA · doi:10.1001/jama.290.16.2129 · Cited by 314
The Gothenburg Breast Screening Trial
Bjurstam, N., Björneld, L., Warwick, J., Sala, E., Duffy, S. W., Nyström, L., Walker, N., Cahlin, E., Eriksson, O., Hafström, L., et al. (2003) · Cancer · doi:10.1002/cncr.11361 · Cited by 308
Chu, K. C., Smart, C. R., & Tarone, R. E. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.14.1125 · Cited by 302
Randomized study of mammography screening — preliminary report on mortality in the stockholm trial
Frisell, J., Eklund, G., Hellström, L., Lidbrink, E., Rutqvist, L. E., & Somell, A. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01975443 · Cited by 258
Periodic Screening for Breast Cancer: The HIP Randomized Controlled Trial
Shapiro, S. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.27 · Cited by 257
Noncancer Deaths in White Adult Cancer Patients
Brown, B. W., Brauner, C., & Minnotte, M. C. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.979 · Cited by 252
Andersson, I., & Janzon, L. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.63 · Cited by 250
Long‐term outcome of the Malmö Preventive Project: mortality and cardiovascular morbidity
Berglund, G., Nilsson, P., Eriksson, K. ‐., Nilsson, J. ‐., Hedblad, B., Kristenson, H., & Lindgärde, F. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00568.x · Cited by 242
Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial
Frisell, J., Lidbrink, E., Hellström, L., & Rutqvist, L.-E. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005872617944 · Cited by 223
Causes of Death in Elderly Prostate Cancer Patients and in a Comparison Nonprostate Cancer Cohort
Newschaffer, C. J., Otani, K., McDonald, M. K., & Penberthy, L. T. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.8.613 · Cited by 214
Validity of Cancer Registry Data for Measuring the Quality of Breast Cancer Care
Malin, J. L., Kahn, K. L., Adams, J., Kwan, L., Laouri, M., & Ganz, P. A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.835 · Cited by 214
FIRST RESULTS ON MORTALITY REDUCTION IN THE UK TRIAL OF EARLY DETECTION OF BREAST CANCER
UKTRIALOFEARLYDETECTIONOFBRE (1988) · The Lancet · doi:10.1016/s0140-6736(88)90410-2 · Cited by 210
Domenighetti, G., D’Avanzo, B., Egger, M., Berrino, F., Perneger, T., Mosconi, P., & Zwahlen, M. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg257 · Cited by 210
Bjurstam, N., Björneld, L., Duffy, S. W., Smith, T. C., Cahlin, E., Eriksson, O., Hafström, L., Lingaas, H., Mattsson, J., Persson, S., et al. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971201)80:11<2091::aid-cncr8>3.0.co;2-# · Cited by 207
Quality of life following a false positive mammogram
Gram, I., Lund, E., & Slenker, S. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.430 · Cited by 205
Slaytor, E. K., & Ward, J. E. (1998) · BMJ · doi:10.1136/bmj.317.7153.263 · Cited by 196
Brett, J., & Austoker, J. (2001) · Journal of Public Health · doi:10.1093/pubmed/23.4.292 · Cited by 189
Breast screening, prognostic factors and survival – results from the Swedish two county study
Duffy, S., Tabar, L., Fagerberg, G., Gad, A., Gröntoft, O., South, M., & Day, N. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.477 · Cited by 174
Relationship Between Mammographic and Histological Risk Factors for Breast Cancer
Boyd, N. F., Jensen, H. M., Cooke, G., & Han, H. L. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.15.1170 · Cited by 173
The Canadian National Breast Screening Study: a critical review.
Kopans, D. B., & Feig, S. A. (1993) · American Journal of Roentgenology · doi:10.2214/ajr.161.4.8372752 · Cited by 165
Nattinger, A. B., Hoffmann, R. G., Kneusel, R. T., & Schapira, M. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02757-4 · Cited by 164
Jørgensen, K. J., & Gøtzsche, P. C. (2004) · BMJ · doi:10.1136/bmj.328.7432.148 · Cited by 158
Self-citationKerlikowske, K. M. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.79 · Cited by 152
Ikeda, D. M., Andersson, I., Wattsgård, C., Janzon, L., & Linell, F. (1992) · American Journal of Roentgenology · doi:10.2214/ajr.159.2.1632342 · Cited by 151
Evaluating periodic multiphasic health checkups: A controlled trial
Dales, L. G., FRIEDMAN, G. D., & Collen, M. F. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90080-8 · Cited by 146
Content of invitations for publicly funded screening mammography
Jørgensen, K. J., & Gøtzsche, P. C. (2006) · BMJ · doi:10.1136/bmj.332.7540.538 · Cited by 145
Self-citationLEAD TIME IN BREAST CANCER DETECTION AND IMPLICATIONS FOR PERIODICITY OF SCREENING1
Shapiro, S., Goldberg, J. D., & Hutchison, G. B. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112046 · Cited by 137
16-year mortality from breast cancer in the UK Trial of Earaly Detection of Breast Cancer
Moss, S. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07412-1 · Cited by 134
The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up
Alexander, F., Anderson, T., Brown, H., Forrest, A., Hepburn, W., Kirkpatrick, A. E., McDonald, C., Muir, B. B., Prescott, R. J., Shepherd, S., et al. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.342 · Cited by 130
On the efficacy of screening for breast cancer
Freedman, D. A. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyg275 · Cited by 128
Screening for breast cancer with mammography
Olsen, O., & G��tzsche, P. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877 · Cited by 122
Self-citationLidbrink, E. K., Elfving, J., Frisell, J., & Jonsson, E. L. (1996) · BMJ · doi:10.1136/bmj.312.7026.273 · Cited by 119
Fink, R., Shapiro, S., & Roester, R. (1972) · American Journal of Public Health · doi:10.2105/ajph.62.3.328 · Cited by 119
Markov Models of Breast Tumor Progression: Some Age-Specific Results
Duffy, S. W., Day, N., Tabár, L. K., Chen, H.-H., & Smith, T. C. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.93 · Cited by 113
Psychiatric morbidity after screening for breast cancer.
Dean, C., Roberts, M. M., French, K., & Robinson, S. E. (1986) · Journal of Epidemiology & Community Health · doi:10.1136/jech.40.1.71 · Cited by 111
Overdiagnosis in Screening: Is the Increase in Breast Cancer Incidence Rates a Cause for Concern ?
Paci, E., Warwick, J., Falini, P., & Duffy, S. W. (2004) · Journal of Medical Screening · doi:10.1177/096914130301100106 · Cited by 108
Attendance at a breast screening clinic: a problem of administration or attitudes.
French, K., Porter, A. M., Robinson, S. E., McCallum, F., Howie, J. G., & Roberts, M. M. (1982) · BMJ · doi:10.1136/bmj.285.6342.617 · Cited by 105
Frisell, J., Glas, U., Hellström, L., & Somell, A. (1986) · Breast Cancer Research and Treatment · doi:10.1007/bf01805924 · Cited by 98
Kopans, D. B., Halpern, E. F., & Hulka, C. A. (1994) · Cancer · Cited by 94
The Edinburgh randomised trial of screening for breast cancer: Description of method
Roberts, M. M., Alexander, F. E., Anderson, T. J., Forrest, A. P. M., Hepburn, W., Huggins, A., Kirkpatrick, A. E., Lamb, J., Lutz, W., & Muir, B. B. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.132 · Cited by 93
Nyström, L., Larsson, L., Wall, S., Rutqvist, L. E., Andersson, I., Bjurstam, N., Fagerberg, G., Frisell, J., & Tabár, L. K. (1996) · Journal of Medical Screening · doi:10.1177/096914139600300208 · Cited by 89
Tabár, L. K., Duffy, S. W., Yen, M.-F., et al. (2002) · Journal of Medical Screening · doi:10.1136/jms.9.4.159 · Cited by 88
Time‐dependent effects on survival in breast carcinoma
Warwick, J., Tabàr, L., Viták, B., & Duffy, S. W. (2004) · Cancer · doi:10.1002/cncr.20140 · Cited by 85
New swedish breast cancer detection results for women aged 40–49
Tabár, L. K., Duffy, S. W., & Burhenne, L. J. W. (1993) · Cancer · doi:10.1002/1097-0142(19930815)72:4+<1437::aid-cncr2820721405>3.0.co;2-m · Cited by 80
Impediments to recruitment in the Canadian National Breast Screening Study: Response and resolution
Baines, C. J. (1984) · Controlled Clinical Trials · doi:10.1016/0197-2456(84)90119-3 · Cited by 80
An Analysis of the Mortality Effect in a Breast Cancer Screening Study
Aron, J. L., & Prorok, P. C. (1986) · International Journal of Epidemiology · doi:10.1093/ije/15.1.36 · Cited by 74
Gray, J. A. (1989) · BMJ · doi:10.1136/bmj.298.6665.48-c · Cited by 73
Tabár, L. K., Chen, H.-H., Fagerberg, G., Duffy, S. W., & Smith, T. C. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.43 · Cited by 72
Moss, S. (1999) · Journal of Medical Screening · doi:10.1136/jms.6.3.144 · Cited by 66
Duffy, S. W., CHEN, H. H., Tabár, L. K., Fagerberg, G., & Paci, E. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.6.1139 · Cited by 65
Evaluation of Periodic Breast Cancer Screening With Mammography
Shapiro, S. (1966) · JAMA · doi:10.1001/jama.1966.03100090065016 · Cited by 65
The case-control design and the assessment of the efficacy of cancer screening
Connor, R., Prorok, P. C., & Weed, D. L. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90154-2 · Cited by 61
Meta-analysis adjusting for compliance: The example of screening for breast cancer
Glasziou, P. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90166-k · Cited by 60
Mammographie screening trials for women aged under 50: A quality assessment and meta‐analysis
Glasziou, P., Woodward, A. J., & Mahon, C. M. (1995) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1995.tb126047.x · Cited by 57
Moody‐Ayers, S. Y., Wells, C. K., & Feinstein, A. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.8.1109 · Cited by 56
Randomisation by cluster and the problem of social class bias.
Alexander, F., Roberts, M. M., Lutz, W., & Hepburn, W. (1989) · Journal of Epidemiology & Community Health · doi:10.1136/jech.43.1.29 · Cited by 45
The role of the nurse-examiner in the National Breast Screening Study.
Miller, A., Baines, C. J., & Turnbull, C. (1991) · PubMed · Cited by 44
Tabar, Vitak, Chen, Prévost, & Duffy (1999) · Swiss Surgery · doi:10.1024/1023-9332.5.5.199 · Cited by 40
Mammographic breast cancer screening —a randomized trial in Malmö, Sweden
Andersson, I., Janzon, L., & Sigfússon, B. F. (1985) · Maturitas · doi:10.1016/0378-5122(85)90031-3 · Cited by 39
Lidbrink, E. K., Frisell, J., Brandberg, Y., Rosendahl, I. K., & Rutqvist, L. E. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00665978 · Cited by 39
An analysis of survival differences between clinically and screen‐detected cancer patients
Habbema, J. D. F., van Oortmarssen, G. J., & van Putten, D. J. (1983) · Statistics in Medicine · doi:10.1002/sim.4780020224 · Cited by 35
Cluster randomization in large public health trials: The importance of antecedent data
Duffy, S. W., South, M. C., & Day, N. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110304 · Cited by 33
Update on effects of screening mammography
Tabár, L. K., Smith, R. A., & Duffy, S. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09523-5 · Cited by 32
The Quality and Interpretation of Mammographic Screening Trials for Women Ages 40-49
Glasziou, P., & Irwig, L. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.73 · Cited by 31
Prognostic indicators for poor risk epithelial ovarian carcinoma
Rosman, M., Hayden, C. L., Thiel, R. P., Chambers, J. T., Kohorn, E. I., Chambers, S. K., & Schwartz, P. E. (1994) · Cancer · doi:10.1002/1097-0142(19940815)74:4<1212::aid-cncr2820740406>3.0.co;2-5 · Cited by 29
Meta-analysis of screening data: a survey of the literature
Walter, S. D., & Jadad, A. R. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19991230)18:24<3409::aid-sim377>3.0.co;2-8 · Cited by 26
Alexander, F. E., O’Brien, F., Hepburn, W., & Miller, M. (1987) · BMJ · doi:10.1136/bmj.295.6601.754 · Cited by 25
Global summit on mammographic screening
Boyle, P. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg318 · Cited by 21
Use of risk factors to allocate schedules for breast cancer screening.
Alexander, F. E., Roberts, M. M., Huggins, A., & Muir, B. B. (1988) · Journal of Epidemiology & Community Health · doi:10.1136/jech.42.2.193 · Cited by 16
Hatschek, T., Carstensen, J. M., Fagerberg, G., et al. (1989) · Breast Cancer Research and Treatment · doi:10.1007/bf01806304 · Cited by 15
Criticisms of Swedish mammography trials were wrong
Tabár, L. K., & Duffy, S. W. (1999) · BMJ · doi:10.1136/bmj.319.7221.1367 · Cited by 5
(1977) · doi:10.1002/1097-0142(197706)39:6<2772::aid-cncr2820390665>3.0.co;2-k
Cited by
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Self-citationSpecial Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Lay health workers in primary and community health care
Lewin, S., Dick, J., Pond, P., Zwarenstein, M., Aja, G. N., van Wyk, B. E., Bosch-Capblanch, X., & Patrick, M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004015.pub2 · Cited by 544
Jorgensen, K. J., & Gotzsche, P. C. (2009) · BMJ · doi:10.1136/bmj.b2587 · Cited by 502
Breast Cancer Screening and Diagnosis
Bevers, T. B., Anderson, B. O., Bonaccio, E., Buys, S., Daly, M. B., Dempsey, P. J., Farrar, W. B., Fleming, I., Garber, J. E., Harris, R. E., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0070 · Cited by 465
Metadata
- Authors
- Gøtzsche, P. C., & Nielsen, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2006-10-18
- Issue
- 4
- Pages
- CD001877-CD001877
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4241473608
- Cited by
- 260
- References
- 111
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.